Physician

Ritesh Patil, M.D.,MPH

According to 2025 Medicare claims, Ritesh Patil, M.D., MPH (NPI: 1699892695) practices hematology/oncology in the Palm Bay-Melbourne-Titusville, FL market, with the plurality of this provider's patient population coming from Brevard, FL. This provider's primary affiliated billing organization is HEALTH FIRST MEDICAL GROUP, LLC (NPI: 1750626495; TIN: 461243081) and primary practice location at 32907-2552. Patil is affiliated with the Privia Quality Network Central Florida, LLC (ACO ID: A4947), participating under the MSSP model.

Patil's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 801 traditional Medicare patients, billed 204,565 HCPCS/CPT codes, and received $2,920,424 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,601 prescription claims across 343 beneficiaries totaling $2,696,066 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 35 claims. Open Payments data shows 1 records totaling $30. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $17,986 to $2,920,424. Similarly, Part D prescription costs have risen steadily, from $512,797 to $2,696,066. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	128	281	$17,986
2016	257	728	$42,928
2017	400	1,860	$124,609
2018	397	1,575	$123,222
2019	307	2,726	$98,497
2020	358	51,632	$851,547
2021	555	137,191	$2,046,370
2022	600	121,464	$2,055,051
2023	746	162,210	$2,362,500
2024	801	204,565	$2,920,424

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	83	424	$512,797
2016	72	384	$876,307
2017	67	156	$221,765
2018	47	164	$287,059
2019	65	251	$156,290
2020	128	748	$612,277
2021	191	1,162	$1,564,788
2022	231	1,141	$1,926,180
2023	277	1,251	$1,357,396
2024	343	1,601	$2,696,066

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	58	$2,432
2023	N/R	N/R	N/R
2024	N/R	35	$757

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	134	154	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	240	672	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	315	478	$62
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	126	315	$62
96372	Injection of drug or substance under skin or into muscle	119	344	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	59	1,456	$721,308
Xtandi	Enzalutamide	33	990	$433,529
Tagrisso	Osimertinib Mesylate	16	720	$359,839
Verzenio	Abemaciclib	14	392	$191,867
Brukinsa	Zanubrutinib	20	584	$190,849

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	14	$494
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	21	$263

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$30	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ritesh Patil, M.D., MPH?

Tedicare shows public-source Medicare data for Ritesh Patil, M.D., MPH (NPI 1699892695), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ritesh Patil, M.D., MPH have ACO affiliation data?

Ritesh Patil, M.D., MPH is shown with ACO affiliation data for Privia Quality Network Central Florida, LLC (MSSP, ACO ID A4947).

What billing organization is linked to Ritesh Patil, M.D., MPH?

Ritesh Patil, M.D., MPH is linked to HEALTH FIRST MEDICAL GROUP, LLC (billing NPI 1750626495) in the available physician profile data.

Does Ritesh Patil, M.D., MPH have Open Payments data?

Ritesh Patil, M.D., MPH has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.